未找到相关数据
Phase I trial of intratumoral administration of autologous CCL21 gene-modified dendritic cells in combination with pembrolizumab for advanced NSCLC: Feasibility of repeated IT injections
被引：1
作者：
Liu, Bin
Lisberg, Aaron
Salehi-Rad, Ramin
Oh, Michael
Lee, Jay M.
Tran, Linh M.
Krysan, Kostyantyn
Lim, Raymond J.
Dumitras, Camelia
Jing, Zhe
Abtin, Fereidoun
Suh, Robert D.
Genshaft, Scott J.
Oh, Scott S.
Fishbein, Gregory A.
Kaul, Anita
Kahlon, Kanwarpal S.
Ashouri, Shahryar A.
Goldman, Jonathan W.
Elashoff, David A.
Garon, Edward
Dubinett, Steven M.
机构：
关键词：
D O I：
10.1158/1538-7445.AM2024-CT153
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT153
引用
收藏
页数：2
相关论文